Bliss GVS Pharma Limited — Major Shareholding Notification 2021

Apr 22, 2021

Gagan H Sharma, 2301, Lako Front Solitaire, AS Marg. Towai, Mumbai 400076
+91 9920955959 | gaganharsh@gmail.com

Date: April 12, 2021

To,	To,	To,
Corporate Relationship Dept.,	Listing Department,	Bliss GVS Pharma Limited
BSE Limited,	National Stock Exchange of	102, Hyde Park, Saki Vihar
Phiroze Jeejeebhoy Towers,	India Ltd.,	Road, Andheri $(East)$ .
Dalal Street,	Exchange Plaza, C-1, Block G,	Mumbai - 400072.
Mumbai-400001.	Bandra Kurla Complex,
Scrip Code: 506197	Bandra (E). Mumbai-400 051
	Symbol: BLISSGVS

Subject: Annual Disclosure pursuant to Regulation 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Dear Sir/Madam,

Please find enclosed herewith the disclosure as required in terms of Regulation 30(2) SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended from time to time.

Kindly acknowledge receipt of the same.

Thanking You

Gagan Harsh Sharma Promoter

Encl: Disclosure

Gagan H Sharma, 2301, Lake Front Solitaire, AS Marg. Powai, Mumbai 400076 +919990955959 gaganharsh@gmail.com

Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1. Name of the Target Company (TC)	BLISS GVS PHARMA LIMITED
2. Name(s) of the stock exchange(s) where the	BSE Limited
shares of the TC are listed	National Stock Exchange of India Limited
3. Particulars of the shareholder(s):
a. Name of person(s) together with Persons Acting in Concert (PAC) whose total holding (including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the TC) is more than 25% of the voting rights of the TC. or b. Name(s) of promoter(s), member of the promoter group and PAC with him.	Not Applicable Gagan Harsh Sharma Shruti Vishal Rao Narsimha Shibroor Kamath (S. N. Kamath)
	Vibha Gagan Sharma
4. Particulars of the shareholding of person(s) mentioned at (3) above	Number of shares	% w.r.t. total share / voting capital wherever applicable	% of total diluted share/voting capital of TC (*)
As of March 31 st 2021, holding of:
a) Shares	# 3,43,57,024	33.31%	NA
b) Voting Rights (otherwise than by shares)	NA	NA	NA
c) Warrants,	NA	NA	NA
d) Convertible Securities	NA	NA	NA
e) Any other instrument that would entitle the holder to receive shares in the TC.	NA	NA	NA
Total	3,43,57,024	33.31%	NA

Part-A- Details of Shareholding:

(#) Out of 3,43,57,024 Equity Shares mentioned above, I Gagan Sharma, Promoter of the company individually holds (0) Equity Shares which stands (0.00%) of total paid up capital of the Company.

Gagan H Sharma, 2301, Lake Front Solitaire, A.S. Marg, Powai, Mumbai 400076 +919920955959 gaganharsh@gmail.com

Part-B**

Name of the Target Company: BLISS GVS PHARMA LIMITED

Name(s) of the person and Persons Acting in Concert (PAC) with the person	Whether the person belongs to Promoter/ Promoter group	PAN of the person and PACs
Narsimha Shibroor Kamath	Yes
Vibha Gagan Sharma	Yes
Gagan Harsh Sharma	Yes
Shruti Vishal Rao	Yes

$\frac{1}{2}$

Gagan Harsh Sharma Promoter

Place: Mumbai Date: April 12, 2021

Note:

1. In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.

(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

(**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.

Gagan H Sharma, 2301. Lake Front Solitaire, AS Marg. Towai, Mumbai 400076
+91 9920955959 gaganharsh@gmail.com

Date: April 12, 2021

To,	To,
Listing Department,	Audti Committee
National Stock Exchange of	Bliss GVS Pharma Limited
	102, Hyde Park, Saki Vihar
Exchange Plaza, C-1, Block G,	Road, Andheri (East).
Bandra Kurla Complex,	Mumbai - 400072.
Bandra (E). Mumbai-400 051
Symbol: BLISSGVS
	India Ltd.,

Subject: Declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011- Yearly Disclosure

Dear Sir/Madam,

Pursuant to the Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011, I, Gagan Harsh Sharma being Promoter of Bliss GVS Pharma Limited, do hereby declare that, I along with person acting in concert with me have not made any encumbrance, directly or indirectly on any shares of Bliss GVS Pharma Limited other than those already disclosed during the financial year to BSE Limited & National Stock Exchange of India Ltd, and to the Audit Committee of the Company.

Further as of March 31, 2021, the Number of encumbered shares by me of Bliss GVS Pharma Limited is - Nil

Gagan Harsh Sharma Promoter

Place: Mumbai